Identification of new HER2/neu-derived peptide epitopes that can elicit specific CTL against autologous and allogeneic carcinomas and melanomas. [electronic resource]
Producer: 19990729Description: 1037-44 p. digitalISSN:- 0022-1767
- Carcinoma -- genetics
- Cell Separation
- Colonic Neoplasms
- Cytotoxicity Tests, Immunologic
- Cytotoxicity, Immunologic
- Epitopes, T-Lymphocyte -- immunology
- Female
- HLA-A2 Antigen -- biosynthesis
- Humans
- Lymphocyte Activation
- Melanoma -- genetics
- Oligopeptides -- chemical synthesis
- Ovarian Neoplasms
- Receptor, ErbB-2 -- biosynthesis
- T-Lymphocytes, Cytotoxic -- immunology
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.